See also this year's filing and all EDGAR filings for this company.
PDF Report 0001867096_2022_Xeris_Biopharma_Holdings_Inc.pdf
Logs
Graph
Absolute values for 0001867096, Xeris Biopharma Holdings Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 142,596,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 154,309,000 |
| 2 | PropertyPlantAndEquipmentNet | 6,627,000 |
| 3 | remainder_Assets | 829,000 |
| 4 | LiabilitiesCurrent | 79,040,000 |
| 5 | LiabilitiesNoncurrent | 1,676,000 |
| 6 | remainder_Liabilities | 128,414,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 125,718,000 |
| 9 | ResearchAndDevelopmentExpense | 25,160,000 |
| 10 | remainder_Expenses | 13,868,000 |
| 11 | remainder_Revenues | 49,590,000 |
| 12 | remainder_NetIncome | -7,569,000 |
| 13 | remainder_ComprehensiveNetIncome | -37,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 304,361,000 |
| 1 | Liabilities | 209,130,000 |
| 2 | Expenses | 164,746,000 |
| 3 | Revenues | 49,590,000 |
| 4 | StockholdersEquity | 95,231,000 |
| 5 | NetIncome | -122,725,000 |
| 6 | ComprehensiveNetIncome | -122,743,500 |
| 7 | BaseVar | 367,716,500 |
| 8 | EconomicCapitalRatio | 0.160 |
Edgar->Model Mapping
Feature Distribution
Change over Time
